Search filters

List of works by Vasilios G. Athyros

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses

scientific article published in September 2011

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary

scientific article published on 01 September 2011

11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?

scientific article published on 30 May 2012

A comparison of the aldosterone-blocking agents eplerenone and spironolactone.

scientific article

A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAS

scientific article published on 01 August 2007

Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI.

scientific article published on 12 November 2013

Additional effects of statins in surgical patients

scientific article published on 01 July 2008

Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?

scientific article published on July 2010

Alanine aminotransferase is associated with metabolic syndrome independently of insulin resistance

scientific article published on 15 June 2011

Alcohol consumption and the heart

scientific article published on 4 May 2013

Angioedema may not be a class side-effect of the angiotensin-converting-enzyme inhibitors

scientific article published on 22 February 2006

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

article by Vasilios G. Athyros et al published 1 April 2007 in Expert Opinion on Pharmacotherapy

Antihypertensive therapy in acute ischemic stroke: where do we stand?

scientific article published on 19 September 2018

Antisense technology for the prevention or the treatment of cardiovascular disease: the next blockbuster?

scientific article published on 01 July 2008

Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women.

scientific article published in November 2011

Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study

scientific article published on 30 June 2011

Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort

scientific article published in December 2007

Atherogenesis in renal patients: a model of vascular disease?

scientific article published on 01 April 2008

Atherosclerotic renal artery stenosis: an update on diagnosis and management

scientific article published on 01 July 2011

Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?

scientific article published on 07 June 2009

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia

scientific article published in July 2002

Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients

scientific article published on 23 August 2007

Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study

scientific article published in January 2001

Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

scientific article

Beliefs and attitudes regarding cardiovascular disease risk factors: a health survey in 10,141 Greek men and women (2006-2012).

scientific article published on 23 July 2013

Bilateral renal artery stenosis and primary aldosteronism in a diabetic patient

scientific article

Blood pressure levels constitute the most important determinant of the metabolic syndrome in a Mediterranean population: a discrimination analysis

scientific article published on 17 August 2010

Brain natriuretic peptide and the athlete's heart: a pilot study

scientific article published in March 2010

CORONA, statins, and heart failure: who lost the crown?

scientific article published in February 2008

Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?

scientific article published on 14 April 2008

Cardiovascular benefits of bariatric surgery in morbidly obese patients ⬇️

scientific article published on February 23, 2011

Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome

scientific article published in February 2010

Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients

scientific article published on 29 May 2013

Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)

scientific article published on 01 October 2018

Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?

scientific article published on 01 April 2008

Colesevelam improves glycemic control and lipid management in inadequately controlled type 2 diabetes mellitus

scientific article published on 18 November 2008

Colesevelam: a new and improved bile acid sequestrant?

scientific article published on January 2013

Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease

scientific article published on 01 July 2013

Comment to "atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property".

scientific article published on 9 October 2012

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study

scientific article published in June 2011

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

scientific article published in March 2010

Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?

scientific article published on 01 January 2010

Current treatment for nonalcoholic fatty liver disease

scientific article published on 6 August 2011

Definitions of metabolic syndrome: Where are we now?

scientific article published in July 2006

Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects.

scientific article published in April 2007

Does metabolic syndrome influence outcome following percutaneous coronary intervention?

scientific article published on 18 March 2011

Dry cough as first manifestation of giant-cell arteritis

scientific article published on 01 December 2006

Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatment ⬇️

scientific article

Dyslipidaemia, hypercoagulability and the metabolic syndrome

scientific article (publication date: July 2006)

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases ⬇️

scientific article published on February 24, 2011

Dysmetabolic iron overload in metabolic syndrome

scientific article published on 29 January 2020

EDITORIAL - Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes? ⬇️

scientific article published on March 22, 2012

Editorial: Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role? ⬇️

scientific article published on December 2, 2011

Editorial: aliskiren/amlodipine single-pill combinations: more evidence in favour of combination formulations for the treatment of hypertension

scientific article published on 01 November 2012

Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?

scientific article published on 01 May 2012

Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study

scientific article published on 01 January 1998

Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factors

scientific article published on 25 November 2009

Effect of aldose reductase inhibition on cardiovascular reflex tests in patients with definite diabetic autonomic neuropathy over a period of 2 years

scientific article published in July 1998

Effect of aldose reductase inhibition on heart rate variability in patients with severe or moderate diabetic autonomic neuropathy

scientific article published in January 1998

Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

scientific article

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

scientific article published in May 2006

Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy

scientific article published in January 2006

Effect of quinapril or metoprolol on circadian sympathetic and parasympathetic modulation after acute myocardial infarction

scientific article published on November 1999

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients

scientific article published in February 1996

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Ev

scientific article published on 23 September 2006

Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease

scientific article

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

scientific article (publication date: March 2005)

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

scientific article published in April 2004

Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients

scientific article published on 20 December 2007

Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness

scientific article

Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia

scientific article published in June 2008

Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study

scientific article published on 21 April 2008

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

scientific article published in October 2004

Effects of various fibrates on serum alkaline phosphatase activity.

scientific article

Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance

scientific article published on 21 September 2011

Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander?

scientific article published on October 2006

Endocrine hypertension: diagnosis and management of a complex clinical entity

scientific article published in September 2010

Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

scientific article published on 14 October 2009

Eplerenone relieves spironolactone-induced painful gynaecomastia in a patient with primary aldosteronism

scientific article published on 02 October 2006

Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?

scientific article published on 01 July 2008

Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity

scientific article published on 19 February 2012

Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review

scientific article (publication date: 2006)

Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study

scientific article published on 01 January 2012

Fish oils and vascular disease prevention: an update.

scientific article published on January 2007

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

scientific article published on April 2011

Has the time come for a new definition of microalbuminuria?

scientific article published on 01 April 2008

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

scientific article published in August 2001

Hypertension and hyperhomocysteinemia as risk factors for chronic kidney disease: A dangerous duo?

scientific article published on 16 September 2019

Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

scientific article published in November 2011

Hyperuricaemia: more than just a cause of gout?

scientific article published on June 2013

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis ⬇️

scientific article published on December 30, 2011

Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

scientific article published on March 2007

Impact of statins on glucose metabolism--a matter of debate

scientific article published on 01 June 2011

Implementation of guidelines for the management of arterial hypertension. The impulsion study

scientific article published on 05 May 2009

Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study

scientific article

Inflammatory markers and the metabolic syndrome.

scientific article published on 28 July 2005

Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study

scientific article published in August 2009

Intravenous immunoglobulins: a valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease

scientific article published on 01 January 2007

Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome?

scientific article published in May 2011

Is there any association between adiponectin gene polymorphisms and cardiovascular disease?

scientific article published on 30 December 2012

JUPITER: major implications for vascular risk assessment

scientific article published on 01 January 2009

Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.

scientific article

Lipid lowering agents and the endothelium: an update after 4 years

scientific article published on 01 January 2012

Lipid-lowering agents and new onset diabetes mellitus

scientific article published in August 2010

Lipid-lowering therapy in patients with peripheral arterial disease

scientific article published on 01 June 2005

Lipid-lowering treatment in peripheral artery disease

scientific article published on 31 January 2018

Lipoprotein a: where are we now?

scientific article published on July 2009

Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis

scientific article published in April 2002

Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.

scientific article published on 17 October 2011

Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

scientific article published in January 2003

Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia

scientific article published in July 2002

Management of statin-intolerant high-risk patients

scientific article published in September 2010

Managing the combination of non-alcoholic fatty liver disease and metabolic syndrome

scientific article published on 13 January 2012

Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease

scientific article published on 07 February 2012

Metabolic syndrome and arterial stiffness: the past, the present and the future

scientific article published in October 2013

Mortality reduction in patients treated with intensive lipid therapy vs usual care. Re: Zhao XQ, Phan BA, Davis J et al. Mortality reduction in patients treated with long-term intensive lipid therapy: 25-year follow-up of the Familial Atherosclerosi

scientific article

Myocardial perfusion scintigraphy in asymptomatic diabetic patients: a critical review.

scientific article published on July 2010

NAFLD and Statins

scientific article published on 14 August 2020

New developments in the treatment and prevention of vascular disease--part 1

scientific article published on 01 January 2010

New-onset diabetes after transplantation

Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options

scientific article published on 01 March 2012

Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment

scientific article

Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations

scientific article published on 18 March 2013

PCI and stable coronary heart disease--COURAGE to change our minds?

scientific article published in July 2007

Peripheral arterial stiffness as a surrogate of central hemodynamics: A new era for cardiovascular risk estimation?

scientific article published on 25 January 2018

Pharmacotherapy: statins and new-onset diabetes mellitus--a matter for debate

scientific article published on 07 February 2012

Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary intervention

scientific article published in March 2013

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study.

scientific article

Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

scientific article published on 18 July 2006

Preventing macrovascular complications of diabetes: where do we stand with glycemic control?

scientific article published on 01 December 2008

Preventing type 2 diabetes mellitus: room for residual risk reduction after lifestyle changes?

scientific article published on January 2010

Primary and secondary coronary heart disease prevention using statins: is targeting Adam or Eve equally effective?

scientific article published on 01 June 2008

Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity

scientific article published on 01 September 2012

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

scientific article published in September 2004

Response to 'Mildly decreased glomerular filtration rate is associated with poor coronary heart disease outcome'

scientific article published on 19 January 2012

Role of antihypertensive drugs in arterial 'de-stiffening' and central pulsatile hemodynamics

scientific article published on June 2012

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

scientific article published on 23 November 2010

Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia

scientific article published on 01 September 1997

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

scientific article published on October 2011

Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients

scientific article published on 01 April 2010

Serum uric acid as an independent predictor of early death after acute stroke

scientific article published in July 2007

Should raising high-density lipoprotein cholesterol be a matter of debate?

scientific article published on April 2012

Should we expand the concept of coronary heart disease equivalents?

scientific article published on July 2014

Smoking and non-alcoholic steatohepatitis (NASH): the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) trial

scientific article published on 07 March 2012

Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism

scientific article published in March 2008

Stage of chronic kidney disease and severity of coronary heart disease manifestation

scientific article published on 15 February 2012

Standardized arrangement for a guideline-driven treatment of the metabolic syndrome: the SAGE-METS study

scientific article published on 01 April 2009

Statin discontinuation: an underestimated risk?

scientific article published on 02 October 2008

Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?

scientific article published on 01 April 2010

Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?

scientific article published on 01 May 2011

Statin-fibrate combination for mixed dyslipidaemia: a limited option?

scientific article published on September 2010

Statin-fibrate combinations in patients with combined hyperlipedemia

scientific article published in March 2001

Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention

scientific article published in July 2009

Statins and heart failure

scientific article published in April 2010

Statins and nonalcoholic fatty liver disease: a bright future?

scientific article published on 29 July 2013

Statins and renal function in patients with diabetes mellitus

scientific article

Statins and renal function. Is the compound and dose making a difference?

scientific article published on 25 January 2007

Statins and solid organ transplantation.

scientific article published on January 2006

Statins for non-alcoholic fatty liver disease: a new indication?

scientific article published on 01 August 2006

Statins for the prevention of first or recurrent stroke

scientific article published on 01 April 2008

Statins in patients with renal dysfunction

scientific article published on 01 May 2012

Targeting vascular risk in patients with metabolic syndrome but without diabetes

scientific article published on August 2005

The DEFINE study: a bright future for CETP inhibitors?

scientific article published on 17 January 2011

The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) Study

scientific article published in September 2004

The effect of cholesterol-lowering treatment on renal function

scientific article published on 01 March 2006

The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome

scientific article published on 05 September 2006

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

scientific article published on July 2004

The natural history of recently diagnosed autonomic neuropathy over a period of 2 years

scientific article published on 01 October 1998

The pharmacokinetic considerations and adverse effects of DPP-4 inhibitors [corrected].

scientific article published on 19 April 2014

The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study.

scientific article published on July 2005

The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions

scientific article published in August 2005

Therapeutic options for statin-intolerant patients

scientific article published on 31 January 2012

Thinking beyond traditional cardiovascular risk factors: the role of arterial stiffness in targeting residual risk

scientific article published on 01 January 2012

To switch (statins) or not to switch? That is the question

scientific article published on 19 October 2010

Total serum insulin-like growth factor-1 and C-reactive protein in metabolic syndrome with or without diabetes

scientific article published on 01 May 2006

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

scientific article published in January 2002

Triglycerides and vascular risk: insights from epidemiological data and interventional studies

scientific article

Undertreatment of dyslipidaemia in Greece

scientific article published on 01 November 2004

Unusual manifestation of diarrhea-associated haemolytic uraemic syndrome in an adult

scientific article

Uric acid levels and vascular disease

scientific article

Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?

scientific article published on 01 September 2010

Vitamin D deficiency, statin-related myopathy and other links with vascular risk

scientific article published on 08 July 2011

Paulina is supported by:

About Paulina

Help